State Street’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $128K | Sell |
103,100
-275,436
| -73% | -$342K | ﹤0.01% | 3934 |
|
2025
Q1 | $462K | Hold |
378,536
| – | – | ﹤0.01% | 3612 |
|
2024
Q4 | $681K | Buy |
378,536
+63,500
| +20% | +$114K | ﹤0.01% | 3560 |
|
2024
Q3 | $1.6M | Buy |
315,036
+256,029
| +434% | +$1.3M | ﹤0.01% | 3392 |
|
2024
Q2 | $420K | Buy |
59,007
+37,307
| +172% | +$265K | ﹤0.01% | 3596 |
|
2024
Q1 | $59.5K | Hold |
21,700
| – | – | ﹤0.01% | 4128 |
|
2023
Q4 | $58.2K | Hold |
21,700
| – | – | ﹤0.01% | 4169 |
|
2023
Q3 | $57.3K | Buy |
21,700
+1,900
| +10% | +$5.02K | ﹤0.01% | 4252 |
|
2023
Q2 | $55.4K | Hold |
19,800
| – | – | ﹤0.01% | 4393 |
|
2023
Q1 | $57.4K | Hold |
19,800
| – | – | ﹤0.01% | 4471 |
|
2022
Q4 | $70.9K | Hold |
19,800
| – | – | ﹤0.01% | 4466 |
|
2022
Q3 | $64K | Hold |
19,800
| – | – | ﹤0.01% | 4602 |
|
2022
Q2 | $60K | Sell |
19,800
-75,270
| -79% | -$228K | ﹤0.01% | 4688 |
|
2022
Q1 | $798K | Buy |
95,070
+1,991
| +2% | +$16.7K | ﹤0.01% | 3880 |
|
2021
Q4 | $974K | Buy |
93,079
+6,978
| +8% | +$73K | ﹤0.01% | 3820 |
|
2021
Q3 | $1.55M | Buy |
+86,101
| New | +$1.55M | ﹤0.01% | 3682 |
|